A qualitative component of a benzodiazepine-reduction program explains implementation variation without proving which component caused reduced prescribing.
Forty Spanish general practitioners from intervention settings discussed barriers and facilitators. Complexity, clinicians’ readiness for change, and stakeholder engagement differentiated higher and lower implementers. The study used a structured implementation framework to organize interviews and ratings.
This publication is not the randomized efficacy comparison itself. Interview interpretation may be influenced by knowing implementation status, and participants did not review the findings for feedback. Patient satisfaction with withdrawal was not assessed.
For a quality-of-care review, distinguish whether an intervention was offered, adopted, delivered correctly, and acceptable to patients. This paper helps identify process questions. It cannot establish that every clinician with lower prescribing implemented a better taper or that an individual patient benefited from the program.
Source reviewed: Evaluating the Implementation of a Multicomponent Intervention Consisting of Education and Feedback (PMC8345522). Forensic applications above are interpretive analysis of the supplied paper.
Related reading: Opioid-Policy Study Examined Benzodiazepine Overlap as a Separate Prescribing Outcome; Japanese Anxiolytic Polypharmacy Claims Lacked the Diagnoses Needed to Explain Prescribing.